Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames Wat.u 35 Regulatory News (AW14)

Share Price Information for Thames Wat.u 35 (AW14)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
AW14 Live PriceLast checked at - London Stock Exchange

Intraday Thames Wat.u 35 Share Chart

Restructuring Plan Upheld

17 Mar 2025 11:16

RNS Number : 9580A
Thames Water Utilities Limited
17 March 2025
 

Thames Water Utilities Limited

17 March 2025

Liquidity Extension Update - Restructuring Plan Upheld 

Thames Water Utilities Limited announces that today the Court of Appeal upheld the restructuring plan to extend the liquidity runway of the Thames Water Group.

Following a decision of the Court of Appeal, the restructuring plan proposed by Thames Water Utilities Holdings Limited pursuant to Part 26A of the Companies Act 2006 (the "Company Plan") in connection with implementing the liquidity extension transaction (the "Liquidity Extension Transaction") and which had been sanctioned by High Court of Justice of England and Wales has been upheld, subject to a limited modification relating to releases by Thames Water Utilities Holdings Limited and TWUL.

Chris Weston, CEO, Thames Water commented: "We are pleased that the Court of Appeal has today decisively refused the appeals and upheld the strong High Court decision to sanction the Company Plan. We remain focused on putting Thames Water onto a more stable financial foundation as we seek a long-term solution to our financial resilience. Today's news demonstrates further progress. We continue to work closely with our creditors, enabling us to access liquidity to continue to implement our turnaround plan so we can deliver better results for our customers and the environment while seeking to attract new capital into the business. As we have previously stated, the Company Plan will not affect customer bills but will provide continued investment in our network to fix pipes, upgrade our sewage treatment works, and maintain high-quality drinking water. We remain of the view that a market led solution is in the best interest of customers, UK taxpayers and the wider economy."

The Company will now work with its creditors to seek to satisfy final conditions precedent to the super senior funding and obtain waivers where applicable - to achieve this the Company expects to launch a STID Proposal and consent requests under the super senior funding shortly, together with certain turnover arrangements. Following the outcome of those consent processes, it is expected that the initial tranche of £1.5 billion would be provided in instalments over the coming months.

TWUL's equity raise process continues to progress in parallel. On 11 February 2025, TWUL announced that it had received proposals from a number of parties and it is now conducting a detailed assessment of each bid. TWUL will provide further updates in relation to the equity raise in due course.

-Ends-

For further information

Investor enquiries

Edwin Lloyd - Head of Investor Relations debt.investorrelations@thameswater.co.uk

Media enquiries

Alex SimmonsEdelman SmithfieldThameswater@edelmansmithfield.com

Suvra Jans - Head of Media Relations Suvra.jans@thameswater.co.uk 07747 640810

Simon Haynes

simon.haynes@thameswater.co.uk

07747 644 910

 

Information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as amended and as it forms part of United Kingdom domestic law ("UK MAR") until the release of this announcement. For the purpose of UK MAR and Article 2 of Commission Implementing Regulating (EU) 2016/1055 as it forms part of United Kingdom domestic law, this announcement is made by Chris Weston (Director) at Thames Water Utilities Limited.

 

LEI: 213800JKM5UQHFJOTZ25

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFDLFFEXLFBBE
12
Date   Source Headline
27th Dec 20247:01 amRNSLiquidity Extension Update
27th Dec 20247:00 amRNSLiquidity Extension Update
20th Dec 20243:02 pmRNSTWUL - STID Proposal
19th Dec 20248:00 amRNSPR24 Final Determination
17th Dec 20246:13 pmRNSLiquidity Extension Update
17th Dec 20241:44 pmRNSLiquidity Extension Update
17th Dec 202410:00 amRNSLiquidity Extension Update
16th Dec 20244:57 pmRNSLiquidity Extension Update
13th Dec 20244:35 pmRNSLiquidity Extension Update
10th Dec 20247:19 amRNSInterim Financial Statements
10th Dec 20247:04 amRNSInterim Financial Statements
22nd Nov 202411:20 amRNSLiquidity Extension Update
18th Nov 20243:41 pmRNSSTID Proposal - Results Announcement
13th Nov 20247:00 amRNSLiquidity Extension Update
25th Oct 20243:14 pmRNSSTID Proposal - Notice of Bondholder Meetings
25th Oct 20243:12 pmRNSSTID Proposal Launch Announcement
25th Oct 20247:00 amRNSLiquidity Extension Update
30th Sep 202410:16 amRNSAnnual Financial Statements
20th Sep 20247:02 amRNSProcess Update
28th Aug 202412:28 pmRNSPR24 Draft Determination Response
31st Jul 20244:56 pmRNSS&P Ratings Action
24th Jul 202412:28 pmRNSMoody's ratings action
9th Jul 20247:00 amRNSAnnual Financial Report
9th Jul 20247:00 amRNSAnnual Financial Report
16th May 20247:00 amRNSDirector Change
22nd Apr 20247:00 amRNSPR24 Business Plan Update
28th Mar 20247:00 amRNSShareholder Funding Update
16th Feb 20248:00 amRNSCompany Information
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.